Nektar Therapeutics (NKTR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Nektar Therapeutics-Aktie (NKTR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.84% 11.18	10.46	29.18	24.12	23.49
Cost Of Revenue	-	-	7.977	4.435	9.74
Operating Expenses	13.80% 47.41	54.99	6.85	54.03	63.52
Benefits Costs and Expenses	11.01% 50.57	56.83	22.17	61.17	75.81
Costs And Expenses	13.80% 47.41	54.99	14.83	58.47	73.26
Depreciation and Amortization	49.77% 0.214	0.426	0.332	0.993	1.459
Operating Income/Loss	18.65% -36.23	-44.53	14.35	-34.34	-49.77
Nonoperating Income/Loss	72.57% -3.165	-1.834	-7.346	-2.703	-2.543
Income/Loss Before Equity Method Investments	15.04% -39.40	-46.37	-	-	-
Income/Loss From Equity Method Investments	46.51% -2.386	-4.461	-	-	-
Income/Loss From Continuing Operations Before Tax	15.04% -39.40	-46.37	7.002	-37.05	-52.32
Income Tax Expense/Benefit	461.54% -0.188	0.052	-0.259	0.009	0.046
Income/Loss From Continuing Operations After Tax	15.54% -39.21	-46.42	7.261	-37.06	-52.36
Net Income/Loss	18.26% -41.59	-50.88	7.261	-37.06	-52.36
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	93.32% 14.09	210.92	1.369	209.25	208.83
Diluted Average Shares	93.32% 14.09	210.92	1.369	209.25	208.83
Basic Earnings Per Share	1,129% -2.95	-0.24	0.04	-0.18	-0.25
Diluted Earnings Per Share	1,129% -2.95	-0.24	0.04	-0.18	-0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.96

1.14%

GMAB

$27.08

4.60%

SMMT

$23.52

1.34%

BNTX

$100.42

0.20%

INSM

$143.50

1.24%

ONC

$336.26

1.27%